Gary D. Berkovitz, MD
NPI 1598799454ActiveIndividual· Pediatrics, Pediatric Endocrinology· Miami, FL
Pediatrics, Pediatric Endocrinology (MD) in Miami, Florida, licensed in FL, with an NPI issued in July 2006. Part D covered 15 prescriptions written in 2024, 93% of them generic. Ipsen Biopharmaceuticals, Inc reported $46.00 in payments in 2024, mostly education.
Overview
| NPI | 1598799454 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 10, 2006 |
| Last updated in NPPES | Jan 29, 2013 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Pediatric Endocrinology Primary | 2080P0205X | ME83000 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pediatric Medicine (FL) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 15 · 17 30-day fills |
|---|---|
| Total drug cost | $1,988 |
| Generic share | 93% of claims |
Industry payments (Open Payments)
- 2024$46.00 · 1 payment from 1 company
Top paying companies in 2024
| Company | Amount | Payments |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $46.00 | 1 |
What the 2024 payments were for
- Education$46.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Pediatrics, Pediatric Endocrinology providers in Miami
- 1891249371
- 1790883858
- 1982654737
- 1013159268
- 1922240167
- 1588158562
- 1083641054
- 1013336874
- 1629483250
- 1518994524
- 1134280621
- 1821185869
All Pediatrics, Pediatric Endocrinology providers in Florida →